Ignite Creation Date:
2025-12-26 @ 10:17 PM
Ignite Modification Date:
2025-12-26 @ 10:17 PM
Study NCT ID:
NCT03483012
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-09
First Post:
2018-02-28
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Atezolizumab + Stereotactic Radiation in Triple-negative Breast Cancer and Brain Metastasis
Sponsor:
Dana-Farber Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-05-01
Start Date Type:
ACTUAL
Primary Completion Date:
2019-11-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-04-30
Completion Date Type:
ESTIMATED
First Submit Date:
2018-02-28
First Submit QC Date:
None
Study First Post Date:
2018-03-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-07-07
Results First Submit QC Date:
None
Results First Post Date:
2023-12-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-02
Last Update Post Date:
2025-12-09
Last Update Post Date Type:
ESTIMATED